Literature DB >> 4352083

The prejunctional actions of some non-depolarizing blocking drugs.

L C Blaber.   

Abstract

1. Trains of end-plate potentials (e.p.p.s) have been recorded from the isolated tenuissimus of the cat. The muscle was paralyzed either by transversely cutting the muscle fibres or by non-depolarizing blocking drugs.2. The following parameters of transmitter synthesis, storage and release have been calculated: the quantal content of the first e.p.p. in the train, the size of the available store, fractional release, quantum size, and the rate of refilling of the available store.3. Tubocurarine and benzoquinonium depressed the rate of refilling of the available store causing its depletion at high rates of stimulation. This was offset by an increase in fractional release, which in the case of tubocurarine was sufficient for the quantal content of the first e.p.p. to be unchanged.4. Dimethyltubocurarine and pancuronium had a similar effect to tubocurarine on the rate of refilling of the store and depletion of the store at high rates of stimulation but did not increase fractional release. There was, therefore, a decrease in the quantal content of the first e.p.p.5. Lignocaine depressed the rate of refilling of the store and depleted the store at high rates of stimulation. Fractional release was also depressed.6. It is suggested that the non-depolarizing drugs have a weak local anaesthetic action retarding the influx of sodium into the nerve terminal which slows the rate of refilling of the store. This effect is due to the quaternary ammonium head. The presence of a phenolic group increases fractional release due either to an increased influx of calcium into the nerve terminal or to a potentiation of the actions of calcium.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4352083      PMCID: PMC1776524          DOI: 10.1111/j.1476-5381.1973.tb08163.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  26 in total

1.  THE EFFECT OF TUBOCURARINE ON ACETYLCHOLINE RELEASE FROM MOTOR NERVE TERMINALS.

Authors:  L BEANI; C BIANCHI; F LEDDA
Journal:  J Physiol       Date:  1964-11       Impact factor: 5.182

2.  Antidromic activity in motor nerves and its relation to a generator event in nerve terminals.

Authors:  G WERNER
Journal:  J Neurophysiol       Date:  1961-07       Impact factor: 2.714

3.  The effect of magnesium on the activity of motor nerve endings.

Authors:  J DEL CASTILLO; B KATZ
Journal:  J Physiol       Date:  1954-06-28       Impact factor: 5.182

4.  Release of acetylcholine at voluntary motor nerve endings.

Authors:  H H Dale; W Feldberg; M Vogt
Journal:  J Physiol       Date:  1936-05-04       Impact factor: 5.182

5.  Prejunctional effect of curare: its relative importance.

Authors:  A Galindo
Journal:  J Neurophysiol       Date:  1971-03       Impact factor: 2.714

6.  Does curare affect transmitter release?

Authors:  A Auerbach; W Betz
Journal:  J Physiol       Date:  1971-03       Impact factor: 5.182

7.  Reduction of transmitter release by D-tubocurarine.

Authors:  J I Hubbard; D F Wilson; M Miyamoto
Journal:  Nature       Date:  1969-08-02       Impact factor: 49.962

8.  Does d-tubocurarine inhibit the release of acetylcholine from motor nerve endings?

Authors:  C C Chang; H C Cheng; T F Chen
Journal:  Jpn J Physiol       Date:  1967-10-15

9.  A quantitative study of end-plate potentials in isolated human muscle.

Authors:  D Elmqvist; D M Quastel
Journal:  J Physiol       Date:  1965-06       Impact factor: 5.182

10.  The action of tubocurarine and atropine on the normal and denervated rat diaphragm.

Authors:  R Beránek; F Vyskocil
Journal:  J Physiol       Date:  1967-01       Impact factor: 5.182

View more
  13 in total

1.  Neuromuscular pharmacology update.

Authors:  C Lee; S K Tsai; T Kubota
Journal:  J Anesth       Date:  1992-07       Impact factor: 2.078

2.  Run-down of neuromuscular transmission during repetitive nerve activity by nicotinic antagonists is not due to desensitization of the postsynaptic receptor.

Authors:  S J Hong; C C Chang
Journal:  Br J Pharmacol       Date:  1991-04       Impact factor: 8.739

3.  Nondepolarizing neuromuscular blocking drugs and train-of-four fade.

Authors:  E P McCoy; F M Connolly; R K Mirakhur; P B Loan; L D Paxton
Journal:  Can J Anaesth       Date:  1995-03       Impact factor: 5.063

4.  The interactions of ouabain with post-tetanic and facilitatory drug potentiations at cat soleus neuromuscular junctions in vivo.

Authors:  W F Riker; M Okamoto; J F Artusio
Journal:  Neurochem Res       Date:  1990-04       Impact factor: 3.996

5.  Stem cell derived phenotypic human neuromuscular junction model for dose response evaluation of therapeutics.

Authors:  Navaneetha Santhanam; Lee Kumanchik; Xiufang Guo; Frank Sommerhage; Yunqing Cai; Max Jackson; Candace Martin; George Saad; Christopher W McAleer; Ying Wang; Andrea Lavado; Christopher J Long; James J Hickman
Journal:  Biomaterials       Date:  2018-02-27       Impact factor: 12.479

6.  Prejunctional modulation of acetylcholine release from the skeletal neuromuscular junction: link between positive (nicotinic)- and negative (muscarinic)-feedback modulation.

Authors:  E S Vizi; G T Somogyi
Journal:  Br J Pharmacol       Date:  1989-05       Impact factor: 8.739

7.  Antibodies to motor nerve terminals: an electrophysiological study of a human myasthenic syndrome transferred to mouse.

Authors:  B Lang; J Newsom-Davis; C Prior; D Wray
Journal:  J Physiol       Date:  1983-11       Impact factor: 5.182

8.  Pre-and post-junctional effects of tubocurarine and other nicotinic antagonists during repetitive stimulation in the rat.

Authors:  A J Gibb; I G Marshall
Journal:  J Physiol       Date:  1984-06       Impact factor: 5.182

9.  Nicotinic antagonist-produced frequency-dependent changes in acetylcholine release from rat motor nerve terminals.

Authors:  L Tian; C Prior; J Dempster; I G Marshall
Journal:  J Physiol       Date:  1994-05-01       Impact factor: 5.182

10.  The nature of the presynaptic effects of (+)-tubocurarine at the mouse neuromuscular junction.

Authors:  C B Ferry; S S Kelly
Journal:  J Physiol       Date:  1988-09       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.